What effects does Alpelisib have?

Alpelisib (Alpelisib) is a targeted drug that belongs to the PI3K inhibitor category and is mainly used to treat breast cancer. Its mechanism of action involves the regulation of cell signaling pathways, especially the inhibition of the PI3K/AKT/mTOR signaling pathway.

The PI3K/AKT/mTOR signaling pathway plays an important role in cell growth, differentiation and survival, and its abnormal activation is closely related to the occurrence and development of various cancers. By selectively inhibiting the α isoform of PI3K, Apelvis blocks the abnormal activation of this signaling pathway, thereby inhibiting the growth and spread of tumor cells.

Apelix is mainly suitable for patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative advanced or metastatic breast cancer who carry PIK3CA gene mutations. PIK3CAGene mutation is one of the most common molecular mutations in breast cancer. The development and application of Apelvis allows for more precise treatment of this specific subgroup of patients.

Clinical study results show that the combination of Apelvis and endocrine therapy has achieved positive results in the treatment of breast cancer for patients carryingPIK3CA mutations. However, the use of Apelvis may be associated with some adverse reactions, such as hyperglycemia, skin inflammation, diarrhea, etc. Therefore, the patient's physical condition needs to be closely monitored during use and adjustments made according to the actual situation.

Apelis has not yet been launched in China, so it is not included in medical insurance. Therefore, patients cannot purchase it domestically and need to purchase Apelis through overseas channels. In foreign countries, the original Apelvis drug is mainly used. There are European and Indian versions of the original drug on the market. The price of the European version of the original drug is as high as tens of thousands of yuan. Relatively speaking, the price of the Indian version of the original drug is around four to five thousand yuan. The price is still relatively cheap. Moreover, the ingredients and efficacy of the European and Indian original drugs are consistent.

xa0